Certified by Founder
Lodge
Maxion Therapeutics
start up
United Kingdom
- Cambridge
- 21/02/2023
- Series A
- $16,000,000
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
- Industry Biotechnology
- Website https://www.maxiontherapeutics.com/
- LinkedIn https://www.linkedin.com/company/maxion-tx/